MAGELLAN LONGEVITY
HomeResearchStudy library › Effects of Gabapentin and Pregabalin on Calcium Homeostasis…
Study summary · Pain, nerves & musculoskeletal medicine

How do the nerve-pain drugs gabapentin and pregabalin affect bone, muscle and cartilage — and what does that mean for physical rehabilitation?

In one paragraph

Gabapentin, a review (Current Osteoporosis Reports 2022, PMID 36149592) — the same α2δ1 subunit is expressed in bone, muscle and cartilage, where it has important roles in skeletal formation, mechanosensation and normal tissue function and repair. No numeric effect size is reported for Gabapentin in the source abstract.

Source: Current Osteoporosis Reports 2022, PMID 36149592 ↗ · Research map · How Magellan grades evidence · evidence confidence: low

Current Osteoporosis Reports · 2022 · PMID 36149592 · DOI 10.1007/s11914-022-00750-x

Plain-English summary written and published by Magellan Longevity · medical review by Gabriel Radu, DO (physiatrist, NPI 1376861765). We summarize what the paper reported — we did not run this study.

The takeaway

Gabapentin and pregabalin relieve nerve pain by blocking the α2δ1 calcium-channel subunit — but that same subunit matters in bone, muscle and cartilage, so long-term use is linked to worse musculoskeletal outcomes and higher fracture risk: a key consideration in physiatry and rehab.

The question

How do the nerve-pain drugs gabapentin and pregabalin affect bone, muscle and cartilage — and what does that mean for physical rehabilitation?

What they tested

Because gabapentinoids act on the α2δ1 calcium-channel subunit that is also expressed in musculoskeletal tissues, long-term use may disrupt the calcium-mediated signaling important for skeletal formation, mechanosensation and tissue repair.

How they did it

A narrative review of the mechanism of action of gabapentinoids and the evidence on how chronic treatment affects the musculoskeletal system.

What they found

Gabapentin (GBP) and pregabalin (PGB), originally antiepileptics and now first-line for neuropathic pain (and often prescribed off-label for migraine and back pain), produce analgesia by selectively binding the α2δ1 auxiliary subunit of voltage-sensitive calcium channels and inhibiting channel function. The same α2δ1 subunit is expressed in bone, muscle and cartilage, where it has important roles in skeletal formation, mechanosensation and normal tissue function and repair. Long-term gabapentinoid use is associated with detrimental musculoskeletal outcomes, including increased fracture risk.

How gabapentinoids may reach the musculoskeletal system
Fig. 2 — By blocking the α2δ1 subunit of voltage-sensitive calcium channels, gabapentinoids ease pain signaling in neurons but may also impair calcium-dependent functions in bone, muscle and cartilage. Reyes Fernandez et al., Curr. Osteoporos. Rep. 2022

What it means

Clinicians guiding rehabilitation should weigh the potential musculoskeletal complications of chronic gabapentinoid use, since these drugs may interfere with the calcium signaling that bone, muscle and cartilage rely on to adapt and heal.

Limitations

Much of the mechanistic evidence comes from preclinical and tissue-level studies; the authors call for more research to define the clinical magnitude of the musculoskeletal risk.

“Long-term use of gabapentinoids is associated with detrimental musculoskeletal outcomes, including increased fracture risk. Understanding potential complications is essential for clinicians to guide appropriate treatments.”— from the published abstract, Current Osteoporosis Reports 2022

The paper at a glance

TitleEffects of Gabapentin and Pregabalin on Calcium Homeostasis: Implications for Physical Rehabilitation of Musculoskeletal Tissues
JournalCurrent Osteoporosis Reports
Year2022
PMID36149592 ↗
DOI10.1007/s11914-022-00750-x ↗
TopicPain, nerves & musculoskeletal medicine

Read the source: PubMed record (authors, abstract, full citation) ↗ · Publisher via doi.org ↗

Molecules & mechanisms in this paper

Each of these is named in the paper’s own words above. Open the monograph for the full mechanism and its other citations.

Cite this page

These citations point at this summary. To cite the original paper with its full author list, use the PubMed record or doi.org.

APA
Magellan Longevity. (2026). How do the nerve-pain drugs gabapentin and pregabalin affect bone, muscle and cartilage — and what does that mean for physical rehabilitation? [Plain-English summary of Current Osteoporosis Reports 2022, PMID 36149592, DOI 10.1007/s11914-022-00750-x]. Magellan Longevity. https://magellanlongevity.com/study/gabapentinoid_msk_calcium.html
BibTeX
@misc{magellan_gabapentinoid_msk_calcium, title = {How do the nerve-pain drugs gabapentin and pregabalin affect bone, muscle and cartilage — and what does that mean for physical rehabilitation?}, author = {{Magellan Longevity}}, year = {2026}, howpublished = {\url{https://magellanlongevity.com/study/gabapentinoid_msk_calcium.html}}, note = {Plain-English summary of PubMed PMID 36149592; DOI 10.1007/s11914-022-00750-x; Current Osteoporosis Reports 2022. Reviewed by Gabriel Radu, DO}, urldate = {2026-08-11} }
Permalink
https://magellanlongevity.com/study/gabapentinoid_msk_calcium.html

Related studies in the Magellan library

All 14 Magellan summaries on pain, nerves & musculoskeletal medicine →

How this summary was made. Every section above restates what the published abstract of PMID 36149592 reports — the question, the design, the numbers, the authors’ own conclusion and their stated limitations. We do not add claims the paper did not make, and we keep negative and no-effect findings in. Magellan’s evidence grades are set from research like this and never from affiliate commissions.

Prefer the interactive version? Open this summary in the Magellan app → · Browse all 314 study summaries →

Educational information, not medical advice. This is a plain-English summary of published research; it is not a treatment recommendation and nothing here is intended to diagnose, treat, cure, or prevent any disease. Individual studies can be wrong, and a single paper rarely settles a question. Talk to your physician before acting on any research, especially if you are pregnant, nursing, or taking medication.